Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
about
Preparation, characterization, and evaluation of dipfluzine-benzoic acid co-crystals with improved physicochemical properties.Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches.Computational Raman spectroscopy of organometallic reaction products in lithium and sodium-based battery systems.Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.Assessment of active pharmaceutical ingredient particle size in tablets by Raman chemical imaging validated using polystyrene microsphere size standards.Bioreactor monitoring with spectroscopy and chemometrics: a review.Investigation of the Sensitivity of Transmission Raman Spectroscopy for Polymorph Detection in Pharmaceutical Tablets.Applicability of UV laser-induced solid-state fluorescence spectroscopy for characterization of solid dosage forms.In-line prediction of drug release profiles for pH-sensitive coated pellets.Moisture-Mediated Interactions Between Amorphous Maltodextrins and Crystalline Fructose.Time-Gated Raman Spectroscopy for Quantitative Determination of Solid-State Forms of Fluorescent PharmaceuticalsConformational polymorphism of the antidiabetic drug chlorpropamide
P2860
Q30669947-ECC399C1-A6B3-4A49-BA5E-300ACE7992B1Q34429157-A39C3016-01AD-4015-900D-9CC2925C87C0Q35326898-7027394A-B8A3-4F18-9735-FA75C08F7900Q37585656-75B7BB6C-0733-443B-A2ED-EF5BD934CA21Q37671845-F0B9F579-AA19-4904-BB01-2B3D47456AF3Q38014269-556E45C5-D84B-40CD-82D1-E1CAE3219720Q38867666-5AC81C28-D72F-40FD-968E-58CE8F162DEAQ43767129-505ADEAD-EA79-496F-8411-0FFAB985D261Q47836109-12C5CA1A-BCC5-480D-8CCB-5354A2C25F6EQ53513951-90F5A873-2CF3-403C-B5CD-75A96815DBFBQ57146448-4DFC287F-F94F-4721-A084-09EB88AA1C30Q58860604-7242B0FB-B0BB-4F7D-88D0-A815CD9F633A
P2860
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@en
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@nl
type
label
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@en
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@nl
prefLabel
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@en
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@nl
P2093
P1476
Perspectives in the use of spectroscopy to characterise pharmaceutical solids.
@en
P2093
Clare J Strachan
Jaakko Aaltonen
Keith C Gordon
Thomas Rades
P304
P356
10.1016/J.IJPHARM.2008.04.043
P407
P577
2008-05-08T00:00:00Z